دورية أكاديمية
Accelerating the Evolution of Immune-Related Enterocolitis Management.
| العنوان: | Accelerating the Evolution of Immune-Related Enterocolitis Management. |
|---|---|
| المؤلفون: | Faleck DM; Gastroenterology, Hepatology & Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Dougan M; Division of Gastroenterology and Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA., Tello M; Agenus Inc, Lexington, MA., Grossman JE; Agenus Inc, Lexington, MA., Moss AC; Division of Gastroenterology, Department of Medicine, Boston Medical Center, Boston, MA., Postow MA; Department of Medicine, Weill Cornell Medical College, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. |
| المصدر: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 10; Vol. 41 (17), pp. 3110-3115. Date of Electronic Publication: 2023 Apr 11. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2003- : Alexandria, VA : American Society of Clinical Oncology Original Publication: New York, N.Y. : Grune & Stratton, c1983- |
| مواضيع طبية MeSH: | Enterocolitis*/therapy, Humans |
| References: | Am J Gastroenterol. 2012 Sep;107(9):1409-22. (PMID: 22890223) J Immunother Cancer. 2019 Apr 2;7(1):93. (PMID: 30940209) Gastroenterology. 2022 Feb;162(2):482-494. (PMID: 34757139) Inflamm Bowel Dis. 2019 Nov 14;25(12):1896-1905. (PMID: 30934053) Expert Opin Drug Saf. 2016;15(4):457-65. (PMID: 26789102) Frontline Gastroenterol. 2020 Apr 3;11(6):427-429. (PMID: 33104078) J Immunother Cancer. 2018 Oct 11;6(1):103. (PMID: 30305177) Clin Cancer Res. 2021 Nov 1;27(21):5993-6000. (PMID: 34376536) J Thorac Oncol. 2021 Oct;16(10):1759-1764. (PMID: 34265432) Lancet Oncol. 2010 Feb;11(2):155-64. (PMID: 20004617) J Clin Oncol. 2019 Oct 20;37(30):2730-2737. (PMID: 31116675) Lancet. 2008 Feb 23;371(9613):660-667. (PMID: 18295023) Cell. 2020 Aug 6;182(3):655-671.e22. (PMID: 32603654) Clin Cancer Res. 2020 May 1;26(9):2085-2086. (PMID: 32102949) Cell. 2021 Mar 18;184(6):1575-1588. (PMID: 33675691) BMJ. 2017 Apr 12;357:j1415. (PMID: 28404617) Therap Adv Gastroenterol. 2016 Jul;9(4):457-62. (PMID: 27366214) Clin Gastroenterol Hepatol. 2020 May;18(6):1393-1403.e1. (PMID: 32007539) J Immunother Cancer. 2018 May 11;6(1):37. (PMID: 29747688) J Clin Oncol. 2015 Oct 1;33(28):3193-8. (PMID: 26282644) J Clin Oncol. 2017 Dec 1;35(34):3815-3822. (PMID: 28915085) N Engl J Med. 2010 Aug 19;363(8):711-23. (PMID: 20525992) Immunotherapy. 2015;7(11):1213-27. (PMID: 26513491) World J Gastroenterol. 2018 Jun 21;24(23):2457-2467. (PMID: 29930467) Aliment Pharmacol Ther. 2020 Nov;52(9):1432-1452. (PMID: 32920854) Ann Oncol. 2010 Aug;21(8):1712-1717. (PMID: 20147741) Eur J Cancer. 2016 Feb;54:139-148. (PMID: 26765102) Clin Gastroenterol Hepatol. 2022 Feb;20(2):468-469. (PMID: 33727165) JAMA Oncol. 2022 Dec 1;8(12):1794-1801. (PMID: 36301521) Curr Opin Gastroenterol. 2020 Jan;36(1):25-32. (PMID: 31609734) J Immunol. 2007 Jul 1;179(1):154-61. (PMID: 17579033) Adv Exp Med Biol. 2018;995:151-157. (PMID: 30539510) Dig Dis Sci. 2009 Nov;54(11):2538-40. (PMID: 19104936) J Natl Compr Canc Netw. 2019 Mar 1;17(3):255-289. (PMID: 30865922) J Clin Oncol. 2021 Dec 20;39(36):4073-4126. (PMID: 34724392) Int Immunopharmacol. 2018 Oct;63:292-298. (PMID: 30130720) Nat Med. 2018 Dec;24(12):1804-1808. (PMID: 30420754) J Clin Oncol. 2017 Dec 1;35(34):3807-3814. (PMID: 28841387) Oncologist. 2022 Apr 5;27(4):e350-e352. (PMID: 35380715) Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):222-234. (PMID: 29512649) Lancet Oncol. 2017 May;18(5):611-622. (PMID: 28359784) Lancet Oncol. 2019 Jan;20(1):e54-e64. (PMID: 30614479) Curr Treat Options Gastroenterol. 2019 Dec;17(4):506-523. (PMID: 31741212) Front Pharmacol. 2021 Nov 01;12:746396. (PMID: 34790122) N Engl J Med. 2017 Oct 5;377(14):1345-1356. (PMID: 28889792) Nat Commun. 2017 Dec 22;8(1):2256. (PMID: 29273790) J Clin Invest. 2012 Nov;122(11):4094-104. (PMID: 23064360) J Crohns Colitis. 2020 Feb 10;14(2):192-204. (PMID: 31504340) Cureus. 2021 Sep 5;13(9):e17729. (PMID: 34659943) Am J Gastroenterol. 2018 Mar;113(3):405-417. (PMID: 29336432) Clin Cancer Res. 2021 Feb 15;27(4):1037-1047. (PMID: 33272982) Clin Gastroenterol Hepatol. 2021 Feb;19(2):238-245.e4. (PMID: 32569749) Ther Adv Chronic Dis. 2019 Mar 26;10:2040622319838443. (PMID: 30937157) J Immunother Cancer. 2021 Nov;9(11):. (PMID: 34789551) Lancet. 2022 Apr 30;399(10336):1718-1729. (PMID: 35367007) Inflamm Bowel Dis. 2019 Jun 18;25(7):1169-1186. (PMID: 30605549) JAMA Netw Open. 2021 Mar 1;4(3):e210313. (PMID: 33646314) Aliment Pharmacol Ther. 2015 Jun;41(11):1094-103. (PMID: 25809869) Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10662-7. (PMID: 21670304) J Immunother Cancer. 2021 Jun;9(6):. (PMID: 34172516) Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. (PMID: 28881921) J Crohns Colitis. 2020 Sep 16;14(9):1316-1329. (PMID: 32170314) Clin Cancer Res. 2020 May 1;26(9):2268-2274. (PMID: 31988197) |
| معلومات مُعتمدة: | P30 CA008748 United States CA NCI NIH HHS |
| تواريخ الأحداث: | Date Created: 20230411 Date Completed: 20230615 Latest Revision: 20240612 |
| رمز التحديث: | 20240612 |
| مُعرف محوري في PubMed: | PMC10256374 |
| DOI: | 10.1200/JCO.22.02914 |
| PMID: | 37040601 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1527-7755 |
|---|---|
| DOI: | 10.1200/JCO.22.02914 |